[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-RPRX":3,"homepage-market-summary":35,"stock-news-RPRX":179},{"ticker":4,"date":5,"profile":6,"dividend":15,"quote":19},"RPRX","2026-10-08",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Royalty Pharma plc Class A Ordinary Shares","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.","100","New York, NY",false,{"dividend_yield":16,"annual_dividend":17,"frequency":18,"next_ex_date":9},1.6723,0.94,"Quarterly",{"close":20,"open":21,"high":22,"low":23,"prev_close":24,"change":25,"percent_change":26,"volume":27,"transactions":28,"vwap":29,"high_52w":30,"low_52w":31,"avg_volume_52w":32,"range_52w_percent":33,"record_count":34},56.21,56.57,56.71,55.13,56.76,-0.55,-0.97,2535375.206429,31441,55.9856,64.38,35.23,3503497.8629530556,72,1587,{"status":36,"indices":37,"watchlist":81,"sectors":103,"benchmarks":158},"success",[38,45,52,60,67,74],{"symbol":39,"name":40,"price":41,"change":42,"pct_change":43,"is_up":14,"sparkline":44,"date":5},"SPX","S&P 500",7765.36,-36.41,-0.47,"0.0,10.5 2.3,12.4 4.6,14.2 6.9,16.0 9.3,11.5 11.6,10.8 13.9,4.8 16.2,4.8 18.5,7.9 20.8,8.0 23.2,6.0 25.5,9.1 27.8,9.8 30.1,10.8 32.4,10.0 34.7,7.0 37.1,4.4 39.4,2.0 41.7,2.9 44.0,4.8",{"symbol":46,"name":47,"price":48,"change":49,"pct_change":50,"is_up":14,"sparkline":51,"date":5},"NDX","NASDAQ 100",30725.81,-434.27,-1.39,"0.0,13.4 2.3,14.8 4.6,16.0 6.9,16.0 9.3,12.9 11.6,11.7 13.9,6.5 16.2,5.0 18.5,6.6 20.8,6.6 23.2,5.8 25.5,7.8 27.8,7.4 30.1,7.0 32.4,6.4 34.7,4.6 37.1,2.9 39.4,2.0 41.7,2.4 44.0,5.1",{"symbol":53,"name":54,"price":55,"change":56,"pct_change":57,"is_up":58,"sparkline":59,"date":5},"DJI","DOW JONES",51232,52,0.1,true,"0.0,2.0 2.3,3.3 4.6,6.0 6.9,11.3 9.3,8.7 11.6,9.5 13.9,6.4 16.2,8.0 18.5,10.9 20.8,12.3 23.2,8.2 25.5,11.2 27.8,12.3 30.1,16.0 32.4,15.8 34.7,13.7 37.1,13.0 39.4,10.8 41.7,13.7 44.0,13.3",{"symbol":61,"name":62,"price":63,"change":64,"pct_change":65,"is_up":14,"sparkline":66,"date":5},"COMP","NASDAQ Composite",27193.34,-345.35,-1.25,"0.0,12.9 2.3,14.2 4.6,16.0 6.9,16.0 9.3,12.2 11.6,11.3 13.9,6.1 16.2,5.1 18.5,7.7 20.8,7.7 23.2,6.6 25.5,8.7 27.8,8.9 30.1,8.4 32.4,8.3 34.7,5.5 37.1,3.1 39.4,2.0 41.7,2.5 44.0,5.5",{"symbol":68,"name":69,"price":70,"change":71,"pct_change":72,"is_up":14,"sparkline":73,"date":5},"RUT","RUSSELL 2000",2775.7,-1.3,-0.05,"0.0,2.0 2.3,4.1 4.6,6.6 6.9,8.1 9.3,6.3 11.6,7.9 13.9,6.1 16.2,4.1 18.5,10.6 20.8,10.9 23.2,10.6 25.5,13.0 27.8,14.2 30.1,15.6 32.4,14.2 34.7,11.1 37.1,8.8 39.4,11.3 41.7,15.8 44.0,16.0",{"symbol":75,"name":76,"price":77,"change":78,"pct_change":79,"is_up":58,"sparkline":80,"date":5},"VIX","CBOE VIX",15.41,0.33,2.19,"0.0,9.5 2.3,4.4 4.6,4.0 6.9,2.0 9.3,11.1 11.6,13.6 13.9,13.4 16.2,16.0 18.5,12.1 20.8,10.2 23.2,13.4 25.5,8.6 27.8,8.7 30.1,7.5 32.4,7.3 34.7,11.6 37.1,10.8 39.4,12.8 41.7,12.5 44.0,11.2",[82,89,96],{"symbol":83,"name":84,"price":85,"change":86,"pct_change":87,"is_up":14,"sparkline":88,"date":5},"NVDA","NVIDIA Corp",230.48,-6.99,-2.94,"0.0,16.0 7.3,12.8 14.7,8.8 22.0,2.4 29.3,2.0 36.7,4.3 44.0,13.3",{"symbol":90,"name":91,"price":92,"change":93,"pct_change":94,"is_up":58,"sparkline":95,"date":5},"AAPL","Apple Inc",340.43,3.76,1.12,"0.0,12.3 7.3,16.0 14.7,11.3 22.0,12.4 29.3,11.4 36.7,7.2 44.0,2.0",{"symbol":97,"name":98,"price":99,"change":100,"pct_change":101,"is_up":14,"sparkline":102,"date":5},"TSLA","Tesla Inc",375,-2.81,-0.74,"0.0,15.6 7.3,16.0 14.7,7.3 22.0,3.0 29.3,2.0 36.7,3.5 44.0,5.0",[104,109,114,119,124,129,134,138,143,148,153],{"name":105,"etf":106,"change":107,"price":108,"is_up":14},"Technology","XLK",-1.79,197.78,{"name":110,"etf":111,"change":112,"price":113,"is_up":58},"Financials","XLF",0.89,54.23,{"name":115,"etf":116,"change":117,"price":118,"is_up":14},"Healthcare","XLV",-0.39,168.16,{"name":120,"etf":121,"change":122,"price":123,"is_up":58},"Consumer Cycl","XLY",0.31,111.7,{"name":125,"etf":126,"change":127,"price":128,"is_up":58},"Consumer Staples","XLP",2.11,83.42,{"name":130,"etf":131,"change":132,"price":133,"is_up":58},"Energy","XLE",2.97,65.24,{"name":135,"etf":136,"change":78,"price":137,"is_up":58},"Industrials","XLI",168.4,{"name":139,"etf":140,"change":141,"price":142,"is_up":58},"Materials","XLB",0.59,49.27,{"name":144,"etf":145,"change":146,"price":147,"is_up":58},"Real Estate","XLRE",0.69,40.85,{"name":149,"etf":150,"change":151,"price":152,"is_up":14},"Utilities","XLU",-0.19,41.07,{"name":154,"etf":155,"change":156,"price":157,"is_up":58},"Comm Services","XLC",0.73,112.07,[159,164,169,174],{"ticker":160,"name":161,"price":162,"change":163,"is_up":14},"SPY","SPDR S&P 500 ETF",773.97,-0.42,{"ticker":165,"name":166,"price":167,"change":168,"is_up":14},"QQQ","Invesco QQQ Trust",747.58,-1.34,{"ticker":170,"name":171,"price":172,"change":173,"is_up":58},"DIA","SPDR Dow Jones ETF",511.65,0.12,{"ticker":175,"name":176,"price":177,"change":178,"is_up":14},"IWM","iShares Russell 2000",277.63,-0.03,{"ticker":4,"count":180,"articles":181},18,[182,188,194,200,206,212,218,224,229,235,241,246,252,257,262,267,272,277],{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"Why Royalty Pharma (RPRX) is Poised to Beat Earnings Estimates Again - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxPNGRBOFhGVm05b2dNSENWZFE3RDdrNHRQVkhhTmNxV2d6dk02MUptazIxc2YwV1JVSzZYVlZTbDlTWWw0VXRSOHNXTk5OYVJmYWtJd0Jna3NNLWdRVEJfRXp3am9lSldGemhBYmUtX3dXNWZnbGRSZm1qSmFISm1reXdLZ0pDZjFIbThCV1BnX21tOTdrWFIxYXo5Yw?oc=5","Thu, 08 Oct 2026 15:10:03 GMT","Why Royalty Pharma (RPRX) is Poised to Beat Earnings Estimates Again Yahoo Finance","Yahoo Finance",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"Royalty Pharma officer proposes $239K share sale | RPRX SEC Filing - Form 144 - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxONlZ6V2J4RmppM3UwWl9fdVg1dnR0azdESjEtcmEzWTNZeXNwY1dEU2I1WG8tN3RMNGlYY052c19mSjdmSWhOdW9fUmNQR2VudDZ3UTRXNDl2aVdxTEl6c2Rtbk4yZ1Jhc0RwUWNycE4tbWhrU19Bc3Z1Tk9LaXhsOE5wMGdhWDdTMFg5LXdsd1NEVU5uZ3pkU2JzTQ?oc=5","Mon, 28 Sep 2026 20:10:01 GMT","Royalty Pharma officer proposes $239K share sale | RPRX SEC Filing - Form 144 Stock Titan","Stock Titan",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $235,594.60 in Stock - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizAFBVV95cUxOYllreFJlZzlrV1ROd1JDeWxWbEk5d3h0R2xmbDBib1JrNG8wZF9jUjJlZFlCMmg2OHp6aG5OUXU2R3Q2cG56aDlKLUl2bEVxR3VCR0lXQnlqLW10MjlLaWhVSEl3TmJ3ZEZhNnhoQnZCQ1l2SVI3NFJUcF8zZkZsVXdxdWJ1SE1jZ0RZRHV5aWN6MjBTTFJqV2tsTjNCaC1XTW5nSmlCUnVsMjBTNjNNTE5VMXZJcUJHMVdJY1JrZWhjdFNNanhYd0VrcFA?oc=5","Mon, 05 Oct 2026 23:17:45 GMT","Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $235,594.60 in Stock MarketBeat","MarketBeat",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"If You Invested $100 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwgFBVV95cUxOOEwzUWhFSXJuTE5BUTJmRjlnYUxRMDdKV29qU0cwZkxMNnpqWWFZQUxhWUw3QnF0SnNCWnFCT2I5TjFQSEd3aDZrZGE5azEyX0hBVHhHLW9ib1c5RE45dUhRWlMzMHFqN3VZVXE1eEFCTmhXYmdnZnBIOVpOMlpUejFvUDV6em1oMFlhT0NKcVlsRzliMDBxVXhUaGxRazVGWW9YSW9RSEZvQWVfUndTUGMtWTg0VGdrcFBocTRVczJOQQ?oc=5","Tue, 29 Sep 2026 20:30:40 GMT","If You Invested $100 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today Benzinga","Benzinga",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"(RPRX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiygFBVV95cUxPNm9rVWlfZENOWkRMYjFnV1Z5YThDQkdsb3BGdHN3M0piWE56OFdFWUowS3otQW45a2wwYXEyc0lDaEVWRmNrYklmbVpsYmJoNDktT3ZSdm5TLV9RVEhjS2U3QkVfSzdQMVZsUE8wTVpZNngtR3VWNnBfd0xqN0lhUmxqNXN4VlBWVzJJYnZndXo4N28yWGFMVDRSQUtNWmxXLXhNRjdZUDRkc0xKc0o1dVRyM1g3dGJOUGtzbDR2SlRQb0VBdzVHZHN3?oc=5","Sat, 03 Oct 2026 18:04:02 GMT","(RPRX) as a Liquidity Pulse for Institutional Tactics Stock Traders Daily","Stock Traders Daily",{"title":213,"link":214,"pubDate":215,"description":216,"source":217},"RPRX: Blockbuster Royalties Were The Hook, Synthetic Financing Drives The Upside - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi7AJBVV95cUxORkRyQzdTUEhfalk5dHllY2hOVHhIeTZVU3MwdkJpd213dzlmZU5ZSnFXVXBKY3ptaTNfRWNrU0Z2YUhlbm0zcU5TV2p2N2Zqd1ZwcEZDU016cUVuUFFIMHNJREhmckpwZTlNYVNSR2c4TnlkX1NvaWl6NDdadFNSbVl5RWVXTGVVNHM3a3VjVC1mVGlaM0F0OGp6eTU0RFBsSkxNNDFESUI3QkRnUk9wZFRnNHRxYVU5T3FQSU1PdlFWbHVSY3llYXJELThrWkJTQ0NlNDRsVmNtb1RiV0wyd3dsT05meWhUZFFEdkZZZUNieGd1ak4yZmlWQUw5ekVybjRFYzlFUXRBY19CSGllNTlJb2RndnEySnZfR0hNU3dEMVJzc0t3ZFJsVWxJTG5NbGliSmpNNlFhSjVQcHhUMzNGZVUzcGVvdWtqMVh1Wng1cFJpc1Z3dmV6cGR2NXYtNzNvUU1DLTh6bENp?oc=5","Wed, 30 Sep 2026 07:00:00 GMT","RPRX: Blockbuster Royalties Were The Hook, Synthetic Financing Drives The Upside Simply Wall Street","Simply Wall Street",{"title":219,"link":220,"pubDate":221,"description":222,"source":223},"Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy? - The Motley Fool","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimAFBVV95cUxOd1ZkTWhXN0VwSDB5Z2Y0Wm45S21CVjE2dVpBekkza0Y3V0k0dk5CeEdEdlJjdE42X2VIMzFwTXNYM3JKZEpTbzRqYXVaQlRXWUZyMS1jX3VxWFd6Z0R1S1E4LVk4T3V6eUlrU0RCcTRRajdMbXVuRnFIRjZKcnBxVXNURTNsVENqX1JNN3FCeWpmVzF1ZXJFZA?oc=5","Thu, 01 Oct 2026 17:30:00 GMT","Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy? The Motley Fool","The Motley Fool",{"title":225,"link":226,"pubDate":227,"description":228,"source":193},"4,126 shares sold under a trading plan by Royalty Pharma (RPRX) EVP Marshall Urist. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxQb1ZKWjh4ZG92Tm1tWGplaF94V1FnS0tpNWM0UExUTFp5M2x6amxSWVFqdDEzY25zcUthM3U5SGUwRTAtTFhDRnRFc1ktakxHRjJYTXRMT1VVU0tTMHlLckNvVklHeXM0ZlFOcU9XSlpUNE1lZ2NRNjNmUmhRVlNlVTdpeGF4UFFaM29LamlLSGVWTnVVaDZIdW51bmlWQlhtXy1LNl8tWm92NnVTdWEzLXlR?oc=5","Wed, 30 Sep 2026 20:32:48 GMT","4,126 shares sold under a trading plan by Royalty Pharma (RPRX) EVP Marshall Urist. Stock Titan",{"title":230,"link":231,"pubDate":232,"description":233,"source":234},"Morgan Stanley Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $67 - Moomoo","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiswFBVV95cUxQdURSd0tQdE5tbXFJZ2JEeGJLTFZjamhoaHZ4OWNUV0NDdGxKLW42ZGtVNkhORnVXX1BSTWtNc0JHQzVscm1XazNPWGVXakZ4ZXBWaGdXNXRscE5GSFh3TUFTYTZHaGY0QlNiQXAtNWs4RGdkQlBMY1d4eFRhQUJGbEktNDNTWTFObjY0MGNWZU11dXRHdzkyNzV2YUR0OTcwRkhOWHp6dExVVmNTWkZUUkFoVQ?oc=5","Thu, 08 Oct 2026 05:39:21 GMT","Morgan Stanley Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $67 Moomoo","Moomoo",{"title":236,"link":237,"pubDate":238,"description":239,"source":240},"RPRX Apr 2027 85.000 call (RPRX270416C00085000) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZkFVX3lxTFBud1B4cGJVYlNhZHM3ZXVVMUVTdERrMHd1bTlXMG9ZYTFBZUlwVlNobzRkcFlZZVZFSDRJcWJKQnY2SER4Q3FFM1dIaENlMGU4MEF4QWtfT0FYbVZvdktzcVA2NnR4dw?oc=5","Mon, 05 Oct 2026 16:18:47 GMT","RPRX Apr 2027 85.000 call (RPRX270416C00085000) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":242,"link":243,"pubDate":244,"description":245,"source":199},"Royalty Pharma (NASDAQ:RPRX) EVP Marshall Urist Sells 4,126 Shares of Stock - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizwFBVV95cUxPZkFGQ1Vyem5zSnJlN3hTN3lTVm9EYTJzZkhSZUptYlRDVTVITE40VXAydjdhSEU5Y1RWQUc1RVI5YVN4dTFmVmwwVXhyMXdTVWp0WWQwVktwY2JTSDY4Skd3cWQza2ZORGVTMDZ5aDNWclNGczdtMGpReW53RnF4WVdrVTNKSzNDRTlxRkc4a1VZQXA4aGxpeU5JRjNMcDJvcmI5WFVWV3hmUER1WWRJZ1pLLUhIOHpCdmNVZkR6TWtrWGYwdWR0bHA4dlVMMU0?oc=5","Wed, 30 Sep 2026 21:14:48 GMT","Royalty Pharma (NASDAQ:RPRX) EVP Marshall Urist Sells 4,126 Shares of Stock MarketBeat",{"title":247,"link":248,"pubDate":249,"description":250,"source":251},"Royalty Pharma (RPRX) Slips 0.82% to $57.16 as Shares Test Mid-Range Support - Large Cap Trends - https:\u002F\u002Fwww.dars.gov.et\u002F","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiswFBVV95cUxPQVB3RDg3MkU3a1BnM0FnNkdhbEUzQWJhUl9lMlhSeHJkRUs1anBWN2dlcUxKRUZKRm14UDlXVmgyVmRRbUdQVFBPZzU5RC1XMVQtVmVjMDNhOGcxMDVsbEdTU1V6TkEtbGVwbDNOTDFQWnZ2QWh2aDFHaGIwS0xZQURkeTlnT1ZoRWRSOXJIVGR2VG83VHpzSzI2NjU1VEVNTVlCLUhEaWNxZWQwcGlIemFsNA?oc=5","Sun, 04 Oct 2026 10:37:15 GMT","Royalty Pharma (RPRX) Slips 0.82% to $57.16 as Shares Test Mid-Range Support - Large Cap Trends https:\u002F\u002Fwww.dars.gov.et\u002F","https:\u002F\u002Fwww.dars.gov.et\u002F",{"title":253,"link":254,"pubDate":255,"description":256,"source":193},"Officer Marshall Urist proposes selling 4,126 Royalty Pharma (RPRX) shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxPOW5fU2F1ZnVtNl9aS0YtOUJtblY0NWo0UHZienpWYnVjMUlWa3RHTi1vc1NWRGtaaGFSeVU0ZFV0WWRzZUJWaWpWM3lZNkxjandUcjltckVFNTJTbl93VGRhMUF4T0QxRGNsdnNvVWV3T0kzX0xkR3JOUS1UaXlRZ3hHOWFNZVNVMlowb0tWYmxKODNEWW1QNTJoTQ?oc=5","Mon, 05 Oct 2026 20:03:18 GMT","Officer Marshall Urist proposes selling 4,126 Royalty Pharma (RPRX) shares. Stock Titan",{"title":258,"link":259,"pubDate":260,"description":261,"source":240},"RPRX Apr 2027 50.000 call (RPRX270416C00050000) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZkFVX3lxTE1KYWdFNzBDc1VUUWJ1elp0OWpxeS1oSThLcE0wSzBFc0RUemNvT0FlbzBvclhjREVfRDF3clozSUk3MkpnaDJ4YWVQbFN0eWpycGdneldFYjl0bllSak1yVFNtM0szQQ?oc=5","Sun, 04 Oct 2026 14:06:15 GMT","RPRX Apr 2027 50.000 call (RPRX270416C00050000) Stock Price, News, Quote & History Yahoo! Finance Canada",{"title":263,"link":264,"pubDate":265,"description":266,"source":199},"527,094 Shares of Royalty Pharma PLC $RPRX Bought by Congress Asset Management Co. - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1wFBVV95cUxNX3FXWmFfWFZGSDlxUHBvd0NMbEpUbDdjNnplbkVldTJ4NmNOUkVpMXFkVWstSE5yYldnTncybkhwZ3U4RkswUnM1UWhycnU4amxoYnZlOVJYVXZxX3lnNTVXcGt5Q2FtVmctb01DcWRkQi1qYkYxdHUyanZsdmRBNjdsaGg2YlNiNVFCYjlrcVBIN08xLXRfd2o4OTFxTVFCdU92WWxZeU42X0k2MGpyQ1pCNGRnNHBCdklmT05wRFN5TjVGVXMyWnY1ZmV5Zk9Nb0sxQlRuaw?oc=5","Wed, 07 Oct 2026 07:24:41 GMT","527,094 Shares of Royalty Pharma PLC $RPRX Bought by Congress Asset Management Co. MarketBeat",{"title":268,"link":269,"pubDate":270,"description":271,"source":193},"At $57.10 a share, Royalty Pharma (RPRX) EVP Marshall Urist sells 4,126 shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxPUnZPLUloUnZKQlh2d2F2TWZXVWZpWmVIaHBKU091RDByYmliTkxLaUFFZjBraXJlck41NnJJajBpLVFRY3lraGJPdWVDUVludjlXdWtOS0RIY2p1eExxdlgxWElieXZBZFhLa1FRLUc3QXZIUDFGaUZnTkduU0k1V3lCUkZZVmtnb2hQdllkRmZDQTBEZXlFZEZzQ29oVmxDQ2RWc1lxTEU4Nk05d1lteWR3?oc=5","Mon, 05 Oct 2026 21:13:23 GMT","At $57.10 a share, Royalty Pharma (RPRX) EVP Marshall Urist sells 4,126 shares. Stock Titan",{"title":273,"link":274,"pubDate":275,"description":276,"source":199},"Royalty Pharma (NASDAQ:RPRX) Rating Lowered to Buy at Wall Street Zen - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxNNG1hU0JObUtjYVJpa2NCM0M0aGFUZmxNSHBzR2lweHZwUXY5UjRGZzY3UjV2aXY1MEFTOGpaNk5xcldaa0RKTXBSbDVXY29GaTlkdDZaaGcyRTI3NEFTV29OZjM1SXBOZWZUdUZfT21pNGxfdWlZT3AwcHpHMXBza1MxX1VYcjR3LURIM25LYlpDQ1lSdUwxN2Y0N19LRTU2T1ZGQk9VeGxQenBYYW1hWU9UVjFCRnEtam9aaWM5bUZxcEhIM1hfUg?oc=5","Sat, 26 Sep 2026 05:39:11 GMT","Royalty Pharma (NASDAQ:RPRX) Rating Lowered to Buy at Wall Street Zen MarketBeat",{"title":278,"link":279,"pubDate":280,"description":281,"source":240},"RPRX 8-K & SEC Filings - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMifkFVX3lxTE04aE9sWHRGd1loRlRRb3NfeF9iM1ZsRWs2ZFIta3c0TGhBN3ItWFYwRExFRTZjaHQ4TkR1Vms0TEdPQ2VqSE5Pd3RYYm5JQXlsUThXQmstc0QtUUZ3dHphb1BsWXpWcGNzamJiWlR5c29NbGYzSE9OWmNGMFg2dw?oc=5","Wed, 07 Oct 2026 05:17:20 GMT","RPRX 8-K & SEC Filings Yahoo! Finance Canada"]